HOLX - Hologic FQ4 2021 Earnings Preview
Hologic (NASDAQ:HOLX) is scheduled to announce FQ4 earnings results on Monday, November 1st, after market close. The consensus EPS Estimate is $1.00 (-51.7% Y/Y) and the consensus Revenue Estimate is $1.04B (-23.0% Y/Y). Hologic saw its Q3 2021 net income jump 95% to $268.4M ($1.04 per diluted share) due to a surge in revenue, in July. Last month, Seeking Alpha contributor Francois Soto called Hologic "an undervalued leader", and said that the "strength in Hologic's COVID-related product can be a catalyst in the company's international expansion strategy". Recently, Hologic signed a definitive agreement to acquire privately held, Bolder Surgical, for ~$160M. Over the last 2 years, HOLX has beaten EPS estimates 63% of the time and has beaten revenue estimates 88% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 11 downward. Revenue estimates have seen 5 upward revisions and 6 downward. The company's shares have gained more than 4% in
For further details see:
Hologic FQ4 2021 Earnings Preview